Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
Published on: January 12, 2024
Fluid bolus therapy in pediatric sepsis: a narrative review
Julian San Geroteo1, Michaël Levy2,3, Julien Gotchac4
1Pediatric Intensive Care Unit, Robert-Debré University Hospital, Paris, France. julian.san-geroteo@aphp.fr.
Insights
Pediatric sepsis, a major child killer, requires careful fluid resuscitation. Current guidelines recommend fluid bolus therapy, but the ideal fluid type, especially balanced crystalloids, remains under investigation for pediatric sepsis management.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Resuscitation science
Background:
- Pediatric sepsis is a leading cause of mortality in children under five globally.
- Recent guidelines emphasize fluid bolus therapy as a cornerstone in managing pediatric septic shock and organ dysfunction.
- The optimal fluid choice for resuscitation, particularly balanced crystalloids, is debated due to limited evidence.
Purpose of the Study:
- To review the current evidence on fluid bolus therapy in pediatric sepsis.
- To discuss the role and efficacy of balanced crystalloids in pediatric sepsis resuscitation.
- To highlight the ongoing debate regarding fluid selection in pediatric sepsis management.
Main Methods:
- Literature review of current evidence on fluid resuscitation in pediatric sepsis.
- Analysis of Surviving Sepsis Campaign guidelines (2020) regarding pediatric sepsis management.
- Discussion of theoretical benefits and clinical data on balanced crystalloids versus other fluid options.
Main Results:
- Fluid bolus therapy is a critical component of pediatric sepsis management.
- Balanced crystalloids are proposed as potentially beneficial, but evidence in pediatrics is limited and debated.
- Adult data on fluid choice in sepsis are not consistently applicable to pediatric populations.
Conclusions:
- Further high-quality research is needed to establish the optimal fluid for pediatric sepsis resuscitation.
- The use of balanced crystalloids in pediatric sepsis requires more investigation to clarify their benefits and risks.
- Clinical practice regarding fluid selection in pediatric sepsis should consider the evolving evidence and ongoing expert discussion.
Abstract:
Leading cause of death in children under five, pediatric sepsis remains a significant global health threat. The 2020 Surviving Sepsis Campaign guidelines revised the management of septic shock and sepsis-associated organ dysfunction in children. In addition to empiric broad-spectrum antibiotics, fluid bolus therapy is one of the cornerstones of management, due to theoretical improvement of cardiac output, oxygen delivery and organ perfusion. Despite a very low level of evidence, the possible benefit of balanced crystalloids in sepsis resuscitation has led to discussion on their position as the ideal fluid. However, the latest adult data are not consistent with this, and the debate is still ongoing in pediatrics. We provide here the current state of knowledge on fluid bolus therapy in pediatric sepsis with emphasis on balanced crystalloids.
Related Concept Videos
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Acute Pyelonephritis II: Diagnostic Studies and Management
Drug Delivery: Enteral Route

